Mason R W, Wilcox D, Wikstrom P, Shaw E N
Department of Biochemistry, Strangeways Research Laboratory, Worts Causeway, Cambridge, U.K.
Biochem J. 1989 Jan 1;257(1):125-9. doi: 10.1042/bj2570125.
The major active forms of cathepsins B and L were identified in Kirsten-virus-transformed mouse fibroblasts by the use of a specific radiolabelled inhibitor, benzyloxycarbonyl-Tyr(-125I)-Ala-CHN2. No other proteins were labelled, demonstrating the specificity of this inhibitor for cysteine proteinases. Cathepsins B and L were distinguished by the use of specific antibodies. One active form of cathepsin B, Mr 33,000-35,000, and two active forms of cathepsin L, Mr 30,000 and 23,000, were identified. The intracellular precursors of these proteins had higher Mr values of 39,000 and 36,000 for cathepsins B and L respectively, as shown by pulse-chase experiments with [35S]methionine-labelled proteins. These did not react with the inhibitor under our culture conditions. The precursor of cathepsin L was secreted whereas the precursor of cathepsin B was not, demonstrating that secretions of the two enzymes are regulated differently. In contrast with results found previously for the purified protein [Mason, Gal & Gottesman (1987) Biochem. J. 248, 449-454], the secreted precursor form of cathepsin L did not react with the inhibitor either, indicating that it is not active and therefore, as such, cannot be directly involved in tumour invasion. The secreted protein did react with the inhibitor when incubated at pH 3.0, showing that the protein can be activated, although this did not occur under our culture conditions.
通过使用一种特异性放射性标记抑制剂苄氧羰基 - 酪氨酸(-125I)- 丙氨腈,在 Kirsten 病毒转化的小鼠成纤维细胞中鉴定出组织蛋白酶 B 和 L 的主要活性形式。没有其他蛋白质被标记,这证明了该抑制剂对半胱氨酸蛋白酶的特异性。通过使用特异性抗体区分组织蛋白酶 B 和 L。鉴定出一种组织蛋白酶 B 的活性形式,分子量为 33,000 - 35,000,以及两种组织蛋白酶 L 的活性形式,分子量分别为 30,000 和 23,000。如用 [35S]甲硫氨酸标记蛋白质的脉冲追踪实验所示,这些蛋白质的细胞内前体分子量分别更高,组织蛋白酶 B 为 39,000,组织蛋白酶 L 为 36,000。在我们的培养条件下,这些前体不与抑制剂反应。组织蛋白酶 L 的前体被分泌,而组织蛋白酶 B 的前体不被分泌,这表明这两种酶的分泌受到不同的调节。与先前对纯化蛋白质的研究结果 [梅森、加尔和戈特斯曼(1987 年)《生物化学杂志》248 卷,449 - 454 页] 相反,组织蛋白酶 L 的分泌前体形式也不与抑制剂反应,这表明它没有活性,因此不能直接参与肿瘤侵袭。当在 pH 3.0 下孵育时,分泌的蛋白质确实与抑制剂反应,这表明该蛋白质可以被激活,尽管在我们的培养条件下这种情况不会发生。